**Author details**

René Opšenák\*, Romana Richterová and Branislav Kolarovszki Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital Martin, Martin, Slovakia

\*Address all correspondence to: opsenak@gmail.com

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**21**

*Etiology and Pathophysiology of the Spina Bifida DOI: http://dx.doi.org/10.5772/intechopen.97467*

> [12] Netto JM et al. Spinal dysraphism: a neurosurgical review for the urologist.

> [13] Trudell AS, Odibo AO. Diagnosis of spina bifida on ultrasound: always termination? Best Pract Res Clin Obstet

[14] Liu J et al. The recurrence risk of neural tube defects (NTDs) in a population with high prevalence of NTDs in northern China. Oncotarget.

[15] Sebold CD et al. Recurrence risks for

neural tube defects in siblings of patients with lipomyelomeningocele.

Genet. Med. 2005;7(1):64-67.

Meningomyelocele.

2016;106:24-34.

2018;1414:31-46.

2018;2018:9203-9985.

1996;144:473-479.

[16] Sahni M, Ohri A. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Mar 24, 2020.

[17] Atta CA et al. Global birth

prevalence of spina bifida by folic acid fortification status: a systematic review and meta-analysis. Am J Public Health.

[18] Blencowe H et al. Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis. Ann N Y Acad Sci.

[19] Bodin CR et al. Ultrasound in Prenatal Diagnostics and Its Impact on the Epidemiology of Spina Bifida in a National Cohort from Denmark with a Comparison to Sweden. Biomed Res Int.

[20] Velie EM, Shaw GM. Impact of prenatal diagnosis and elective termination on prevalence and risk estimates of neural tube defects in California, 1989-1991. Am J Epidemiol.

Rev Urol. 2009;11(2):71-81.

Gynaecol. 2014;28(3):367-377.

2017;8(42):72577-72583.

[1] Venkataramana NK. Spinal dysraphism. J Pediatr Neurosci.

[2] Iftikhar W, De Jesus O. Spinal

StatPearls. Treasure Island (FL): StatPearls Publishing; August 10, 2020.

Dis Primers. 2015;1:15007.

Dysraphism And Myelomeningocele. In:

[3] Copp AJ el al. Spina bifida. Nat Rev

[4] Oakeshott P et al. Open spina bifida: birth findings predict long-term outcome.

[5] Yi Y et al. Economic burden of neural tube defects and impact of prevention with folic acid: a literature review. Eur J

[6] Sahmat A et al. The Prevalence and Distribution of Spina Bifida in a Single Major Referral Center in Malaysia. Front

[7] Windham GC et al. The association of twinning and neural tube defects: studies in Los Angeles, California, and Norway. Acta Genet Med Gemellol (Roma). 1982;31(3-4):165-172.

[8] Bhandari J, Thada PK. Neural Tube Disorders. In: StatPearls. Treasure Island (FL): StatPearls Publishing; April

[9] Zaganjor I et al. Describing the Prevalence of Neural Tube Defects Worldwide: A Systematic Literature Review. PLoS ONE. 2016;11(4):151-586.

[10] Bauer SB et al. Urodynamic evaluation of boy with myelodysplasia

[11] Mehrotra A et al. Cervicothoracic Spinal Dysraphism: Unravelling the Pandora's Box. J Pediatr Neurosci.

and incontinence. Urology.

1977;10(4):354-362.

2019;14(4):203-210.

Arch Dis Child. 2012;97:474-476.

Pediatr. 2011;170:1391-1400

Pediatr. 2017;5:237.

13, 2020.

2011;6(Suppl 1):31-40.

**References**

*Etiology and Pathophysiology of the Spina Bifida DOI: http://dx.doi.org/10.5772/intechopen.97467*
